2024/05/28 更新

写真a

ヒロタ カオル
廣田 薫
Hirota Kaoru
所属
付属病院 ワクチン療法研究施設 所長
職名
所長
外部リンク

論文

  • Identification of an antigenic epitope in Helicobacter pylori urease that induces neutralizing antibody production. 国際誌

    K Hirota, K Nagata, Y Norose, S Futagami, Y Nakagawa, H Senpuku, M Kobayashi, H Takahashi

    Infection and immunity   69 ( 11 )   6597 - 603   2001年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    We previously reported a mouse monoclonal antibody (MAb), termed L2, specific for Helicobacter pylori urease strongly inhibited its enzymatic activity. Here, to gain insight into how this antibody affects urease activity, the epitope that was recognized by the antibody was determined. By screening a panel of overlapping synthetic peptides covering the entire sequence of the two subunits (UreA and UreB), we identified a stretch of UreB-derived 19 amino acid (aa) residues (UB-33; aa 321 to 339, CHHLDKSIKEDVQFADSRI) that was specifically recognized by the L2 antibody. Further sequential amino acid deletion of the 19-mer peptide from either end allowed us to determine the minimal epitope as 8 amino acid residues (F8; SIKEDVQF) for L2 reactivity. This epitope appears to lie exactly on a short sequence which formed a flap over the active site of urease, suggesting that binding of the L2 antibody sterically inhibits access of urea, the substrate of urease. Finally, immunization of rabbits with either the 19-mer peptide or the 8-mer minimal epitope resulted in generation of antiurease antibodies that were capable of inhibiting the enzymatic activity. Since urease is critical for virulence of H. pylori, antigenic peptides that induce production of antibodies to inhibit its enzymatic activity may potentially be a useful tool as a vaccine for prevention and treatment of H. pylori infection.

    PubMed

    researchmap